Skip to content
ClinCalc Pro
Menu
Calculators Drugs Pathways AI Dx Donate Get the App
Antimicrobial bath emollient (benzalkonium / chlorhexidine / triclosan)

Emollient bath and shower products, antimicrobial-containing

Brand names: Dermol 600, Oilatum Plus

Antimicrobial-containing emollient bath and shower products combine a skin-softening emollient base with an antiseptic, used as adjuncts in dry, eczematous or infection-prone skin.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

The emollient base reduces transepidermal water loss and restores the skin barrier, while the incorporated antimicrobial reduces skin surface bacterial colonisation.

Prescribing in practice

  • Products used in baths and showers make surfaces dangerously slippery; warn patients (and carers of children and older people) of the slip and fall risk.
  • Discontinue if the antiseptic component causes irritation or sensitisation, which can mimic or worsen the underlying eczema.
  • They are adjuncts and do not replace leave-on emollients or appropriate treatment of established infection.

Monitoring

No laboratory monitoring is required; review skin condition, tolerability and any signs of contact reaction to the antiseptic.

Counselling the patient

  • Take care entering and leaving the bath or shower as the product makes surfaces very slippery.
  • Rinse the bath afterwards and avoid getting product in the eyes.
  • Continue leave-on emollients regularly throughout the day.

Evidence & guidelines

Emollient therapy is a cornerstone of eczema management in NICE guidance; routine addition of antiseptics is reserved for selected infection-prone cases.

Reference: NICE CKS Eczema; BAD; MHRA fire risk DSU; Confirm identity and dosing against the manufacturer SPC (eMC) and NICE. Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.

Calculators
Pathways